Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Asset Resilience Ratio

Latest as of September 2025: 0.62%

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) has an Asset Resilience Ratio of 0.62% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Gen Ilac ve Saglik Urunleri Sanayi ve Ti (GENIL) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

TL106.64 Million
≈ $2.39 Million USD Cash + Short-term Investments

Total Assets

TL17.28 Billion
≈ $387.06 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Gen Ilac ve Saglik Urunleri Sanayi ve Ti (GENIL) total assets.

Liquid Assets Composition Over Time

This chart breaks down Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read GENIL current and long-term liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents TL0.00 0%
Short-term Investments TL106.64 Million 0.62%
Total Liquid Assets TL106.64 Million 0.62%

Asset Resilience Insights

  • Limited Liquidity: Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS maintains only 0.62% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Industry Peers by Asset Resilience Ratio

Compare Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Beijing Tongrentang Co Ltd
SHG:600085
Drug Manufacturers - Specialty & Generic 0.50%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Neuland Laboratories Limited
NSE:NEULANDLAB
Drug Manufacturers - Specialty & Generic 9.65%
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
Drug Manufacturers - Specialty & Generic 1.18%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.01%

Annual Asset Resilience Ratio for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (2022–2024)

The table below shows the annual Asset Resilience Ratio data for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.75% TL92.52 Million
≈ $2.07 Million
TL12.31 Billion
≈ $275.73 Million
-0.08pp
2023-12-31 0.83% TL92.90 Million
≈ $2.08 Million
TL11.13 Billion
≈ $249.39 Million
-10.52pp
2022-12-31 11.35% TL418.01 Million
≈ $9.36 Million
TL3.68 Billion
≈ $82.48 Million
--
pp = percentage points

About Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS

IS:GENIL Turkey Drug Manufacturers - Specialty & Generic
Market Cap
$1.12 Billion
TL49.95 Billion TRY
Market Cap Rank
#8393 Global
#65 in Turkey
Share Price
TL11.10
Change (1 day)
-5.13%
52-Week Range
TL7.17 - TL216.90
All Time High
TL216.90
About

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV… Read more